Role of neoadjuvant chemotherapy in the treatment of stage 1 breast cancer

[1]  T. Powles,et al.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Hortobagyi,et al.  Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery. , 1994, Surgical oncology.

[3]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[4]  Goldie Jh.  Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. , 1987 .

[5]  D. Ingram,et al.  Timing of surgery during the menstrual cycle for breast cancer: possible role of growth factors. , 1995, European journal of cancer.

[6]  M. Baum,et al.  Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. , 1993, European journal of cancer.

[7]  A. Luini,et al.  Primary chemotherapy for resectable breast cancer. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[8]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[9]  R. York.  The medical management of breast cancer. , 1987, Journal of the Medical Association of Georgia.